Breaking News
Get 50% Off 0
🔥 Premium AI-powered Stock Picks from InvestingPro Now up to 50% Off CLAIM SALE
Close

Moderna Inc (MRNA)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Moderna's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
120.37 -0.96    -0.79%
23:53:24 - Real-time Cboe. Currency in USD ( Disclaimer )
Type:  Equity
Market:  United States
  • Volume: 781,924
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 118.80 - 121.98
Moderna 120.37 -0.96 -0.79%

MRNA Income Statement

 
Featured here, the Income Statement (earnings report) for Moderna Inc, showing the company's financial performance from operating and non operating activities such as revenue, expenses and income for the last 4 periods (either quarterly or annually).
AnnualQuarterly
Advanced Income Statement
Period Ending: 2024
31/03
2023
31/12
2023
30/09
2023
30/06
Total Revenue 167 2811 1831 344
Revenue 167 2793 1757 293
Other Revenue, Total - 18 74 51
Cost of Revenue, Total 1159 2335 3401 1879
Gross Profit -992 476 -1570 -1535
Total Operating Expenses 1433 2805 3843 2211
Selling/General/Admin. Expenses, Total 274 470 442 332
Research & Development 1063 1406 1160 1148
Depreciation / Amortization 36 4 419 -
Interest Expense (Income) - Net Operating - -6 -10 -13
Unusual Expense (Income) - - - -
Other Operating Expenses, Total -1057 -1404 -1150 -1135
Operating Income -1266 6 -2012 -1867
Interest Income (Expense), Net Non-Operating - - - -
Gain (Loss) on Sale of Assets - -22 -37 22
Other, Net -101 -42 -17 -140
Net Income Before Taxes -1165 70 -1958 -1749
Provision for Income Taxes 10 -147 1672 -369
Net Income After Taxes -1175 217 -3630 -1380
Minority Interest - - - -
Equity In Affiliates - - - -
U.S GAAP Adjustment - - - -
Net Income Before Extraordinary Items -1175 217 -3630 -1380
Total Extraordinary Items - - - -
Net Income -1175 217 -3630 -1380
Total Adjustments to Net Income - - - -
Income Available to Common Excluding Extraordinary Items -1175 217 -3630 -1380
Dilution Adjustment -2.26 3.08 0.93 -0.78
Diluted Net Income -1172.74 213.92 -3630.93 -1379.22
Diluted Weighted Average Shares 382 395 381 381
Diluted EPS Excluding Extraordinary Items -3.08 0.542 -9.53 -3.62
DPS - Common Stock Primary Issue - - - -
Diluted Normalized EPS -1.91 0.146 -3.15 -2.91
* In Millions of USD (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the income statement, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

MRNA Comments

Write your thoughts about Moderna Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email